PRKN and cancer: The initial mechanisms by which Parkin is activated and identification of bona fide substrates have been mainly studied in human cancer lines overexpressing Parkin, and to date, very few studies have assessed its molecular function in physiologically relevant neuron cell types at the endogenous level.